Lung Cancer (Sept 2014) | Targeted Therapies: Lung Cancer

Next-Generation Sequencing Tests in NSCLC

November 07, 2014

Clinical Articles

A key to improved outcomes for patients with non-small cell lung cancer (NSCLC) is the ability to identify the wide spectrum of genetic changes present in tumors. Doing so will guide treatment decisions and influence the development of much-needed additional targeted therapies.

Treatment Focus: What New Research Means for Crizotinib

November 06, 2014

Clinical Articles

In one retrospective study, Berge et al analyzed records of patients with ALK rearrangements treated with pemetrexed followed by crizotinib, and reported improved outcomes compared with patients receiving crizotinib followed by pemetrexed.